Myosin 9 anticorps (Middle Region)
-
- Antigène Voir toutes Myosin 9 (MYH9) Anticorps
- Myosin 9 (MYH9)
-
Épitope
- Middle Region
-
Reactivité
- Humain, Souris, Rat, Chien, Porc, Cobaye, Lapin
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Myosin 9 est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- DAMNREVSSL KNKLRRGDLP FVVPRRMARK GAGDGSDEEV DGKADGAEAK
- Homologie
- Dog: 93%, Guinea Pig: 86%, Human: 100%, Mouse: 86%, Pig: 93%, Rabbit: 86%, Rat: 93%
- Attributs du produit
- This is a rabbit polyclonal antibody against MYH9. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Affinity Purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the middle region of human MYH9
- Top Product
- Discover our top product MYH9 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 1960 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Dlc1 interaction with non-muscle myosin heavy chain II-A (Myh9) and Rac1 activation." dans: Biology open, Vol. 5, Issue 4, pp. 452-60, (2016) (PubMed).
: "
-
Dlc1 interaction with non-muscle myosin heavy chain II-A (Myh9) and Rac1 activation." dans: Biology open, Vol. 5, Issue 4, pp. 452-60, (2016) (PubMed).
-
- Antigène
- Myosin 9 (MYH9)
- Autre désignation
- MYH9 (MYH9 Produits)
- Synonymes
- anticorps BDPLT6, anticorps DFNA17, anticorps EPSTS, anticorps FTNS, anticorps MHA, anticorps NMHC-II-A, anticorps NMMHC-IIA, anticorps NMMHCA, anticorps C80049, anticorps D0Jmb2, anticorps E030044M24Rik, anticorps Fltn, anticorps Myhn-1, anticorps Myhn1, anticorps NMHC II-A, anticorps NMHCIIA, anticorps NMMHC II-a, anticorps NMMHC-A, anticorps TU72.6, anticorps fi22c04, anticorps myh9, anticorps myh9l2, anticorps wu:fi22c04, anticorps wu:fj85e11, anticorps zgc:162029, anticorps zgc:66164, anticorps NMMHC, anticorps myosin, anticorps non-muscle, anticorps nonmuscle, anticorps KLG/PTK7, anticorps dfna17, anticorps epsts, anticorps ftns, anticorps nmhc-ii-a, anticorps nmmhca, anticorps myosin heavy chain 9, anticorps myosin, heavy polypeptide 9, non-muscle, anticorps myosin, heavy chain 9a, non-muscle, anticorps myosin, heavy chain 9, non-muscle, anticorps myosin, heavy chain 9, non-muscle L homeolog, anticorps MYH9, anticorps Myh9, anticorps myh9a, anticorps myh9.L
- Sujet
-
MYH9 is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain. The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.
Alias Symbols: DFNA17, EPSTS, FTNS, MGC104539, MHA, NMHC-II-A, NMMHCA, BDPLT6, NMMHC-IIA
Protein Interaction Partner: HUWE1, UBC, TP53, SUMO2, SUMO3, IVNS1ABP, LGR4, MDM2, RPA3, RPA2, RPA1, EED, MYL6, MYH14, CDC73, OTUD6B, AKAP10, MYL12A, MYL9, TARDBP, FN1, UBD, PIK3C3, ACE, CSNK2A1, ACTB, PAN2, ITGA4, HSP90AB1, HSP90AA1, ESR1, CASP4, IQCB1, VCAM1, PPP2CA, Fcho2, TRAF3IP
Protein Size: 1960 - Poids moléculaire
- 226 kDa
- ID gène
- 4627
- NCBI Accession
- NM_002473, NP_002464
- UniProt
- P35579
- Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Integrin Complex
-